As biotech firms promise life extension, a more crucial debate emerges: who benefits \u2014 and who\u2019s left behind in a future of engineered longevity?<\/p>\n\n\n\n
In 2025, startups and labs are racing to unlock aging\u2019s secrets. Telomere therapies, senolytics, AI-driven drug repurposing, and regenerative medicine all promise to extend healthy years.<\/p>\n\n\n\n
But extending life isn\u2019t just about technology \u2014 it\u2019s about justice.<\/p>\n\n\n\n
If only the wealthy access longevity advances, social disparities could widen dramatically. Imagine a society where only the top percentile secures decades more, while others still age under current constraints.<\/p>\n\n\n\n
Moreover, there are philosophical and resource questions: how many lives can Earth support at sustained longevity? How do social systems, pensions, and intergenerational equity adjust?<\/p>\n\n\n\n
The longevity race demands more than lab breakthroughs \u2014 it demands public debate, regulatory frameworks, and inclusive access planning.<\/p>\n\n\n\n
For readers, this is more than sci-fi. It\u2019s the frontier of what it means to live \u2014 and live well.<\/p>\n<\/body>","protected":false},"excerpt":{"rendered":"
As biotech firms promise life extension, a more crucial debate emerges: who benefits \u2014 and who\u2019s left behind in a future of engineered longevity?<\/p>\n","protected":false},"author":1,"featured_media":971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[38],"tags":[],"class_list":["post-970","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-wellness"],"yoast_head":"\n